JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
38 hedge funds and large institutions have $16.8M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-2
Holders Change %
-5%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
8
Closed
3
Calls
$298K
Puts
$203K
Net Calls
+$95K
Net Calls Change
+$83K
Top Buyers
| 1 |
1
BlackRock
New York
|
$3.12M |
| 2 |
AIC
2
AWM Investment Company
New York
|
$475K |
| 3 |
JAM
3
JW Asset Management
Miami Beach,
Florida
|
$1.84M |
| 4 |
4
Renaissance Technologies
New York
|
$1.47M |
| 5 |
AG
5
Algert Global
San Francisco,
California
|
$514K |
